Our group was the pioneer in the characterization of the molecular mechanism by which recombinant granulysin induces the death of tumor cells [4,5], demonstrating that it fundamentally induces apoptosis in various tumor cells of hematopoietic origin. The gene discussed is GNLY; the disease is neoplasm.